# Fecal Microbiota Therapy Versus Standard Therapy in Decompensated NASH Related Cirrhosis: A Randomized Controlled Trial.

> **NCT02868164** · NA · WITHDRAWN · sponsor: **Institute of Liver and Biliary Sciences, India**

## Conditions studied

- NASH Related Decompensated Cirrhosis

## Interventions

- **DRUG:** Fecal Microbiota Transplantation
- **DRUG:** Standard Treatment
- **OTHER:** Weight Reduction

## Key facts

- **NCT ID:** NCT02868164
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-02
- **Primary completion:** 2019-02
- **Final completion:** 2019-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** lack of funds
- **Last updated:** 2019-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02868164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02868164, "Fecal Microbiota Therapy Versus Standard Therapy in Decompensated NASH Related Cirrhosis: A Randomized Controlled Trial.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02868164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*